Plaque Psoriasis - Epidemiology Forecast to 2030

Plaque Psoriasis - Epidemiology Forecast to 2030

Summary

Plaque psoriasis is a common and incurable chronic immune-mediated skin disease characterized by red and flaky patches that are itchy and can be painful during flareups which can last for several weeks to months (Mayo Clinic, 2020). Plaque psoriasis is the most common form of psoriasis, affecting between 80% and 90% of individuals living with psoriasis, and can occur on any area of the body such as the scalp, hands, and feet (National Psoriasis Foundation, 2018).

GlobalData epidemiologists relied on the most robust country-specific data for each segmentation covered in this forecast, obtained from scientific studies published in peer-reviewed academic journals, international healthcare agency publications, nationwide neonatal registries, and national disease surveillance agencies available at the time of publication. This report includes a 10-year forecast for the lifetime diagnosed prevalent cases of plaque psoriasis from 2020-2030. The prevalent cases of plaque psoriasis are further segmented by sex and age. Plaque psoriasis data are further segmented by severity (mild, moderate, and severe) and plaque psoriasis cases with psoriatic arthritis.

In the 7MM, the lifetime diagnosed prevalent cases of plaque psoriasis will increase from 15,726,350 in 2020 to 16,856,548 in 2030, at an Annual Growth Rate (AGR) of 0.72% per year. Similarly, lifetime diagnosed prevalent cases of psoriasis in the 5EU (France, Germany, Italy, Spain, and the UK) will increase at an AGR of 0.55%, from 7,779,141 in 2020 to 8,210,874 in 2030. When examining the AGR by individual markets, GlobalData estimates that the US will have the highest number of plaque psoriasis cases in 2030, with 8,171,859 cases at an AGR of 0.93%. Conversely, Japan will have the least number of cases by 2030, with 473,815 cases at an AGR of 0.08%.

Scope

  • The plaque psoriasis epidemiology report provides an overview of the risk factors, comorbidities, and global and historical trends for plaque psoriasis in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan).
  • The report includes a 10-year epidemiological forecast for the lifetime diagnosed prevalent cases of plaque psoriasis segmented by sex and age (0-17 years, 18-29 years, and by 10-year age groups for age 30 years up to 80 years and older) in these markets. The lifetime diagnosed prevalent cases are further segmented by severity and plaque psoriasis cases with psoriatic arthritis in the adult population.
  • The plaque psoriasis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in plaque psoriasis.
Reasons to Buy

The Plaque Psoriasis Epidemiology series will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global plaque psoriasis markets.
  • Quantify patient populations in the global plaque psoriasis markets to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for plaque psoriasis therapeutics in each of the markets covered.
  • Understand magnitude of the plaque psoriasis population by age, sex, severity, and comorbidities.


1 Plaque Psoriasis: Executive Summary
1.1 Catalyst
1.2 Related Reports
1.3 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.1.1 Risk Factors and Comorbidities
2.2 Global and Historical Trends
2.3 Forecast Methodology
2.3.1 Sources
2.3.2 Forecast Assumptions and Methods
2.4 Epidemiological Forecast for Plaque Psoriasis (2020-2030)
2.4.1 Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis
2.4.2 Age-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis
2.4.3 Sex-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis
2.4.4 Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis by Severity in the Adult Population
2.4.5 Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis with PsA in the Adult Population
2.5 Discussion
2.5.1 Epidemiological Forecast Insight
2.5.2 COVID-19 Impact
2.5.3 Limitations of the Analysis
2.5.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
3.3 Contact Us
List of Tables
Table 1: Summary of Newly Added Data Types and Countries
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for Plaque Psoriasis
List of Figures
Figure 1: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, Both Sexes, All Ages, 2020 and 2030 (N)
Figure 2: 7MM, Lifetime Diagnosed Prevalence of Pediatric Plaque Psoriasis (%), Boys and Girls, Ages ≤17 Years, 2020
Figure 3: 7MM, Lifetime Diagnosed Prevalence of Adult Plaque Psoriasis (%), Men and Women, Ages ≥18 Years, 2020
Figure 4: Sources Used for Lifetime Diagnosed Prevalent Cases of Pediatric Plaque Psoriasis
Figure 5: Sources Used and Not Used for Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis in Adults
Figure 6: Sources Used for Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis by Severity Among Adults
Figure 7: Sources Used for Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis with PsA Among Adults
Figure 8: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, Men and Women, All Ages, 2020 (N)
Figure 9: Age-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, 7MM, Men and Women, 2020 (N)
Figure 10: 7MM, Sex-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, All Ages, 2020 (N)
Figure 11: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis by Severity, Men and Women, ≥18 Years, 2020
Figure 12: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis with Psoriatic Arthritis, Men and Women, ≥18 Years, 2020 (N)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook